(Q33274369)

English

Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

0 references

immunohistochemistry

1 reference

based on heuristic

inferred from title

Markku Miettinen

1

object named as

Markku Miettinen

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

4

object named as

Jerzy Lasota

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

3

object named as

Janusz Rys

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Maarit-Sarlomo Rikala

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Zeng-Feng Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

The American Journal of Surgical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

629-639

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Molecular and clinical aspects of targeting the VEGF pathway in tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

21 June 2018

Claudin-5 as an immunohistochemical marker for angiosarcoma and hemangioendotheliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

31 October 2018

Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

31 October 2018

VEGFR2 expression and relationship between tumor neovascularization and histologic characteristics in oral squamous cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

31 October 2018

K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRalpha in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

31 October 2018

Growth inhibition by tyrosine kinase inhibitors in mesothelioma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

31 October 2018

Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

31 October 2018

Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310951

31 October 2018

Differential expression of KDR/VEGFR-2 and CD34 during mesoderm development of the early human embryo

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD31 expression in intratumoral macrophages: a potential diagnostic pitfall

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Expression in Squamous Cell Carcinomas of the Head and Neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factors and receptors in colorectal cancer: Implications for anti-angiogenic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22314185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/PAS.0B013E318243555B

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33274369&oldid=2031346069"